Developments in the prevention of transfusion-associated graft-versus-host disease

British Journal of Haematology

Volumn 158, Issue 5, 2012, Pages 563-568

  Fast, Loren D ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Animal model; Blood transfusion; Cellular immunology; Graft versus host disease

Indexed keywords

AMOTOSALEN; AMUSTALINE; AZIRIDINE DERIVATIVE; INACTINE; PEN 110; RIBOFLAVIN; UNCLASSIFIED DRUG;

BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CLINICAL PROTOCOL; DISEASE ASSOCIATION; GAMMA IRRADIATION; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION PREVENTION; LEUCOREDUCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION;

BLOOD CELLS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; GAMMA RAYS; GRAFT VS HOST DISEASE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; POLYAMINES; SEPSIS; ULTRAVIOLET THERAPY;

EID: 84865118239     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09197.x     Document Type: Review

References (41)

1. Akahoshi, M., Takanashi, M., Masuda, M., Yamashita, H., Hidano, A., Hasegawa, K., Kasajima, T., Shimizu, M., Motoji, T., Oshimi, K. & Mizoguchi, H. (1992) A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion, 32, 169-172.
2. Benjamin, R.J., Mccullough, J., Mintz, P.D., Snyder, E., Spotnitz, W.D., Rizzo, R.J., Wages, D., Lin, J.S., Wood, L., Corash, L. & Conlan, M.G. (2005) Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients. Transfusion, 45, 1739-1749.
3. Dwyre, D.M. & Holland, P.V. (2008) Transfusion-associated graft-versus-host disease. Vox Sanguinis, 95, 85-93.
4. + cells are responsible for the rapid elimination of allogeneic donor lymphoid cells. Journal of Immunology, 157, 4805-4810.
5. Fast, L.D. (2000) Recipient elimination of allogeneic lymphoid cells: donor CD4+ cells are effective alloantigen presenting cells. Blood, 96, 1144-1149.
6. Fast, L.D., Valeri, C.R. & Crowley, J.P. (1995) Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease. Blood, 86, 3090-3096.
7. ™ PEN110 treatment. Transfusion, 42, 1326-1332.
8. Fast, L.D., Semple, J.W., Dileone, G., Kim, M., Freedman, J., Chapman, J. & Purmal, A. (2004) Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs. Transfusion, 44, 282-285.
9. Fast, L.D., Dileone, G., Cardarelli, G., Li, J. & Goodrich, R. (2006) Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/- gamma c-/- double knockout mice. Transfusion, 46, 1553-1560.
10. Fast, L., Nevola, M., Tavares, J., Reddy, H., Goodrich, R. & Marschner, S. (2012) Treatment of whole blood with riboflavin plus UV light, an alternative to gamma-irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion, doi: 10.1111/j.1537-2995.2012.03715.x. [Epub ahead of print].
11. Gilstad, C., Roschewski, M., Wells, J., Delmas, A., Lackey, J., Uribe, P., Popa, C., Jardeleza, T. & Roop, S. (2012) Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood. Transfusion, 52, 930-935.
12. Goulmy, E. (2006) Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Human Immunology, 67, 433-438.
13. Grass, J.A., Wafa, T., Reames, A., Wages, D., Corash, L., Ferrara, J.L. & Lin, L. (1999) Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood, 93, 3140-3147.
14. Hayashi, H., Nishiuchi, T., Tamura, H. & Takeda, K. (1993) Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood. Anesthesiology, 79, 1419-1421.
15. Hoffmann-Fezer, G., Gall, C., Zengerle, U., Kranz, B. & Thierfelder, S. (1993) Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice. Blood, 81, 3440-3448.
16. King, K.E. & Ness, P.M. (2011) How do we prevent transfusion-associated graft-versus-host disease in children? Transfusion, 51, 916-920.
17. King, M.A., Covassin, L., Brehm, M.A., Racki, W., Pearson, T., Leif, J., Laning, J., Fodor, W., Foreman, O., Burzenski, L., Chase, T.H., Gott, B., Rossini, A.A., Bortell, R., Shultz, L.D. & Greiner, D.L. (2009) Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clinical and Experimental Immunology, 157, 104-118.
18. Krishnan, S., Setty, Y., Betal, S.G., Vijender, V., Rao, K., Dampier, C. & Stuart, M. (2010) Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises. British Journal of Haematology, 148, 797-804.
19. Kruskall, M.S., Lee, T.H., Assmann, S.F., Laycock, M., Kalish, L.A., Lederman, M.M. & Busch, M.P. (2001) Survival of transfused donor white blood cells in HIV-infected recipients. Blood, 98, 272-279.
20. Lang, P.O., Govind, S. & Aspinall, R. (2012) Reversing T cell immunosenescence: why, who, and how. Age (Dordr), doi: 10.1007/s11357-012-9393-y [Epub ahead of print].
21. Lee, T.H., Donegan, E., Slichter, S. & Busch, M.P. (1995) Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood, 85, 1207-1214.
22. Lin, L., Conlan, M.G., Tessman, J., Cimino, G. & Porter, S. (2005) Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment. Transfusion, 45, 1610-1620.
23. Luban, N. (2001) Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components. Seminars in Hematology, 38, 34-45.
24. Luban, N.L., Drothler, D., Moroff, G. & Quinones, R. (2000) Irradiation of platelet components: inhibition of lymphocyte proliferation assessed by limiting-dilution analysis. Transfusion, 40, 348-352.
25. Marschner, S., Fast, L.D., Baldwin, W.M., 3rd, Slichter, S.J. & Goodrich, R.P. (2010) White blood cell inactivation after treatment with riboflavin and ultraviolet light. Transfusion, 50, 2489-2498.
26. Mintz, P.D. (2011) Cesium cessation? An advantage of pathogen reduction treatments. Transfusion, 51, 1369-1376.
27. Ohto, H. (1997) Gamma radiation does not prevent transfusion-induced HLA alloimmunization. Transfusion, 37, 878-879.
28. Ohto, H. & Anderson, K.C. (1996) Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients. Transfusion Medicine Review, 10, 31-43.
29. Ohto, H., Yasuda, H., Noguchi, M. & Abe, R. (1992) Risk of transfusion-associated graft-versus-host disease as a result of direct donations from relatives. Transfusion, 32, 691-693.
30. Otsubo, H. & Yamaguchi, K. (2008) Current risks in blood transfusion in Japan. Japanese Journal of Infectious Disease, 61, 427-433.
31. Pelszynski, M.M., Moroff, G., Luban, N.L., Taylor, B.J. & Quinones, R.R. (1994) Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood, 83, 1683-1689.
32. Puliaev, R.A., Puliaeva, I.A., Ryan, A.E. & Via, C.S. (2005) The parent-into-F1 model of graft-vs-host disease as a model of in vivo T cell function and immunomodulation. Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents, 5, 575-583.
33. van Rijn, R.S., Simonetti, E.R., Hagenbeek, A., Hogenes, M.C., De Weger, R.A., Canninga-Van Dijk, M.R., Weijer, K., Spits, H., Storm, G., Van Bloois, L., Rijkers, G., Martens, A.C. & Ebeling, S.B. (2003) A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- gammac-/- double-mutant mice. Blood, 102, 2522-2531.
34. Roychowdhury, S., Blaser, B., Freud, A., Katz, K., Bhatt, D., Ferketich, A., Bergdall, V., Kusewitt, D., Baiocchi, R. & Caligiuri, M. (2005) IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood, 106, 2433-2435.
35. Sabloff, M., Chandy, M., Wang, Z., Logan, B.R., Ghavamzadeh, A., Li, C.K., Irfan, S.M., Bredeson, C.N., Cowan, M.J., Gale, R.P., Hale, G.A., Horan, J., Hongeng, S., Eapen, M. & Walters, M.C. (2011) HLA-matched sibling bone marrow transplantation for beta-thalassemia major. Blood, 117, 1745-1750.
36. Sandhu, J.S., Gorczynski, R., Shpitz, B., Gallinger, S., Nguyen, H.P. & Hozumi, N. (1995) A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes. Transplantation, 60, 179-184.
37. Smith, C., Miles, J.J. & Khanna, R. (2012) Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure. American Journal of Transplantation, 12, 15-26.
38. Solheim, B.G. (2008) Pathogen reduction of blood components. Transfusion and Aphersis Science, 39, 75-82.
39. Spellman, S., Warden, M.B., Haagenson, M., Pietz, B.C., Goulmy, E., Warren, E.H., Wang, T. & Ellis, T.M. (2009) Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biology of Blood and Marrow Transplantation, 15, 856-863.
40. Stainsby, D., Jones, H., Asher, D., Atterbury, C., Boncinelli, A., Brant, L., Chapman, C.E., Davison, K., Gerrard, R., Gray, A., Knowles, S., Love, E.M., Milkins, C., Mcclelland, D.B., Norfolk, D.R., Soldan, K., Taylor, C., Revill, J., Williamson, L.M. & Cohen, H. (2006) Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfusion Medicine Review, 20, 273-282.
41. Via, C.S. (2010) Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens. Current Opinions in Rheumatology, 22, 493-498.